| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Overview of nanoparticle effects 0.8507946805059932 2.8334954338808855 0.0046041965743812 0.9346085435146234 0.0647876232252221 2 P09601 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.7868958806357407 2.5373234887657117 0.0111703682453703 0.9986914507196022 0.0929815159579417 2 Q07812 1 |
| Mecp2 and associated rett syndrome 0.6322681254085161 2.5123899704466774 0.0119916493211147 0.99919920080645 0.0969116992901965 21 Q13451,P67809,P42345,Q00013,O75376,P52597,Q13547,Q05086,Q03518 9 |
| Robo4 and vegf signaling pathways crosstalk 0.7807330522218521 2.50820979399477 0.0121344598096015 0.999264773469508 0.0969116992901965 2 O94813 1 |
| Ovarian infertility 0.8731343283582068 2.449564815631217 0.0143028964907878 0.9997993695253544 0.1017861150021038 3 Q8WXH0,P11802 2 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.8721589983969473 2.4454522098992366 0.0144670620307558 0.9998181782301848 0.1017861150021038 3 Q15758 1 |
| Congenital generalized lipodystrophy cgl 0.7392150502756978 2.3095397428417517 0.0209136489524386 0.999996239818315 0.1346138888419756 2 P31751 1 |
| Nocgmppkg mediated neuroprotection 0.8400002543800837 2.3087920546911755 0.0209551231361451 0.9999963327871408 0.1346138888419756 3 P07196 1 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.8034435761938139 2.1509685875057034 0.0314786791608514 0.999999993826539 0.1898357080006449 3 P09601 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.7949493715594158 2.1139268653834877 0.0345215142469335 0.99999999903866 0.1932437815371504 3 P42345 1 |
| Histone modifications 0.7694864760219753 2.1085133780252865 0.0349866068096025 0.99999999927689 0.1932437815371504 10 Q03164,Q15047 2 |
| Ciliopathies 0.6516991431754525 2.0693171134827937 0.0385163387624483 0.9999999999170784 0.2088362954918069 14 Q9NQH7,Q9NVR5,Q13432 3 |
| Complement and coagulation cascades 0.6879662666234146 2.058285717806784 0.0395627143709154 0.9999999999564302 0.2106447224613604 2 P49257 1 |
| Cell cycle 0.4470224734540603 1.9994429898456003 0.0455604444413855 0.9999999999989252 0.2274974366314241 46 P42771,P61981,Q9UJX3,Q13616,Q9H1A4,P14635,Q9Y619,P25205,Q8N3U4,Q13547,Q9UJX4,P24941,Q13416,O14757,P11802,Q9UBD5 16 |
| Dna damage response 0.547587363328566 1.9901237117674704 0.0465773093610868 0.9999999999994276 0.2274974366314241 22 Q9BXW9,Q13794,P14635,Q07812,O14757,P24941,P49959,P41440,P11802,Q00535 10 |
| Urea cycle and related diseases 0.6707752189425762 1.9725657531862884 0.0485450580281778 0.9999999999998312 0.2275044304940174 2 Q9Y619 1 |
| Thermogenesis 0.5160239185044746 1.969563389834171 0.0488884309183421 0.9999999999998636 0.2275044304940174 27 P33121,O43772,P50416,P51812,Q9UKU0,Q12824 6 |
| Dna replication 0.5031510585054956 1.9531651127265444 0.0508000335350136 0.9999999999999584 0.2332114744845326 29 P40938,P49736,Q9Y619,P25205,P49005,P24941,Q13416,P41440,Q9UBD5 9 |
| Translation factors 0.4851285551269859 1.925836718345869 0.0541247650676726 0.9999999999999948 0.2387040071208583 33 O15372,P60228,Q05639,P55010,O15371,O75153,P19525,O75822,P23588,P05198 10 |
| Mirna regulation of dna damage response 0.5308593703438987 1.921876132388942 0.0546213457151951 0.9999999999999962 0.2387040071208583 23 Q9BXW9,Q13794,P38398,P14635,Q8WXE1,Q07812,P33993,O14757,P24941,P49959,P41440,P11802,Q00535,Q92878 14 |
| Mitochondrial long chain fatty acid betaoxidation 0.6087737384964415 1.9209690066196468 0.0547356149645406 0.9999999999999964 0.2387040071208583 15 P11310,P33121,O43772 3 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8353226892756658 1.9162436239954213 0.055334093021248 0.9999999999999976 0.2387040071208583 6 Q14739,Q15392 2 |
| Neuroinflammation 0.6532598118715429 1.8845254184425553 0.0594939399035228 0.9999999999999998 0.2476121019928308 2 P42345 1 |
| Dna mismatch repair 0.5522311013938839 1.8780048601273336 0.060380500223391 1.0 0.2495445848393293 19 P41440,Q9UQ84 2 |
| Cerebral organic acidurias including diseases 0.825541596975773 1.8615867161088913 0.0626613671536875 1.0 0.2523702836334577 5 P48735,P49419 2 |
| Sulfation biotransformation reaction 0.7376995672091899 1.860800859775318 0.0627723040509615 1.0 0.2523702836334577 3 O43252 1 |
| Genes controlling nephrogenesis 0.809722155330414 1.8116735051484705 0.0700366598184678 1.0 0.2688114541783394 6 Q9Y5K6,Q13418,O94813 3 |
| Retinoblastoma gene in cancer 0.433386535376032 1.797099451126266 0.07231983285001 1.0 0.2688114541783394 44 P40938,P31350,P00374,P14635,Q9Y619,P25205,P33993,Q13547,Q14527,P56282,P24941,Q16204,O14757,P11802 14 |
| Cytosine methylation 0.7978447556285813 1.7490958565611916 0.0802744513417144 1.0 0.2878619718719205 5 P48735 1 |
| Circadian rhythm genes 0.4399893044271017 1.7485573990864602 0.0803675555987595 1.0 0.2878619718719205 40 Q13616,Q03164,O75376,P50416,P43490,Q13547,P11802,Q05086 8 |
| Development of ureteric collection system 0.7935828829121414 1.7317037028762328 0.0833263310226994 1.0 0.2913956309728722 5 Q13418,O94813 2 |
| Ppar signaling pathway 0.5244427126612101 1.6928836231059363 0.0904776211769613 1.0 0.3055558520890523 19 P50416,P11310,P33121,O15254 4 |
| Ethanol effects on histone modifications 0.6567783298105665 1.6795590636430078 0.0930431380870597 1.0 0.3106694610703521 11 Q96KQ7,P41440,Q13547,P00374 4 |
| Mitochondrial complex i assembly model oxphos system 0.4601137722398902 1.658725178723456 0.0971711833005883 1.0 0.3188387983895536 31 Q9NPL8,O43676,P03886,O95168,Q96CU9,O96000,Q9GZY4,Q9P0J0 8 |
| Fragile x syndrome 0.4540711285818871 1.6359990555703003 0.1018397850549677 1.0 0.3288924205873547 32 P42771,Q9NZ01,Q00610,P62993,P50570,P42345,P50416,O95782,P80404,Q96CW1,P28288,Q9Y4R8,Q96F07,P63010,P17252,P06730,Q7L576 17 |
| Nucleotidebinding oligomerization domain nod pathway 0.7658065946913154 1.6304325285021424 0.1030101144475346 1.0 0.330864008904853 6 Q9P0J0,Q96RT1,Q9Y2Z0 3 |
| Mthfr deficiency 0.7427691222125826 1.6147909553626234 0.1063559724865397 1.0 0.3379375254814246 7 Q96KQ7,P49419 2 |
| G1 to s cell cycle control 0.4720824828151664 1.5428072236976378 0.1228775562730217 1.0 0.3746880238562286 24 P42771,Q14181,P49736,P14635,Q9Y619,P25205,P33993,P56282,P24941,Q13416,P11802,Q9UBD5 12 |
| Overview of interferonsmediated signaling pathway 0.5844956211482253 1.532929594717337 0.1252932030693578 1.0 0.3760166133144174 2 P17252 1 |
| Oxidative phosphorylation 0.4342318904648076 1.52761991685775 0.1266069338005278 1.0 0.3763168137573817 34 O75964,P03886,O95168,O96000,P00846,P56134 6 |
| Pkcgamma calcium signaling pathway in ataxia 0.5822251054167984 1.5211890947661029 0.1282123913000268 1.0 0.3788676162915792 2 P23634 1 |
| Pparalpha pathway 0.694439472043262 1.490973764615204 0.1359683830184153 1.0 0.3952073671548123 8 P50416,P11310 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.5740711077316943 1.4892682071316532 0.1364167561752651 1.0 0.3952073671548123 13 P60228,P55010,O15371,O75822,P05198 5 |
| Purinergic signaling 0.652822842310187 1.4761123336491633 0.1399137384240543 1.0 0.4014030068379421 3 P63096,P08754 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7310881512984251 1.4647638543002457 0.1429853566942531 1.0 0.4082335546198242 4 P09601 1 |
| Atr signaling 0.6489292667099306 1.4582728651197585 0.1447653464676785 1.0 0.4113284603961444 3 O14757,Q8WXE1 2 |
| Fatty acid betaoxidation 0.4601408397868159 1.370115497969132 0.1706508507205781 1.0 0.4626360219076225 22 P11310,P33121,O43772 3 |
| Integrated cancer pathway 0.5148218822538697 1.359244619230817 0.1740690866261764 1.0 0.4681625382142672 15 P38398,Q07812,P24941,P49959,O14757,P43246,P11802,Q92878 8 |
| 1q211 copy number variation syndrome 0.6134983176187364 1.3517977929937266 0.1764400103721182 1.0 0.4711789756646515 10 Q9NPH0 1 |
| Proteasome degradation 0.3981939218434137 1.343321803373632 0.1791677950341932 1.0 0.4727150306482509 39 P60900,P04439,P28074,O00231,P20618,Q15008,P04843,Q99436,P28070,P28072,P49721,Q9UL46,P25787,P10321 14 |
| Insulin signaling in adipocytes normal condition 0.6798182949273003 1.2541119202985485 0.2098013282444695 1.0 0.5423598242653402 4 P42345,P31751 2 |
| Insulin signaling in adipocytes diabetic condition 0.6798182949273003 1.2541119202985485 0.2098013282444695 1.0 0.5423598242653402 4 P42345,P31751 2 |
| Hedgehog signaling pathway wp4249 0.6793476319000304 1.2521776621687448 0.2105051336735921 1.0 0.5423598242653402 4 O43791,P48729 2 |
| Sudden infant death syndrome sids susceptibility pathways 0.4225548417611634 1.2481166062657634 0.2119883577077725 1.0 0.5423598242653402 27 P11310 1 |
| Apoptosis modulation and signaling 0.5298396084927179 1.2429566710305118 0.2138838006010921 1.0 0.5425121294216543 13 P42771,Q13794,Q07812,Q07820,O95831 5 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.6742826639534321 1.2390715131344845 0.2153190155442264 1.0 0.5438185392591358 5 P09601 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.666201155801913 1.2142394243820585 0.2246563097620852 1.0 0.5576263187766003 6 Q07812,P10620 2 |
| Rett syndrome causing genes 0.4880275368467918 1.1980448293137531 0.230899565196871 1.0 0.5662308839475136 15 Q8WXH0,O75376,Q9BZK7 3 |
| Mirna regulation of p53 pathway in prostate cancer 0.6634547310251109 1.1869123221353688 0.2352622063924236 1.0 0.5721809217198452 4 O14681,Q13794 2 |
| Electron transport chain oxphos system in mitochondria 0.3464756273563292 1.1540163247080204 0.2484934762022357 1.0 0.5935607031318212 54 O43676,P13073,O75964,P03886,O95168,O96000,P00846,Q16718,P56134 9 |
| T cell receptor and costimulatory signaling 0.5824140168721543 1.152916806332908 0.2489445331615905 1.0 0.5935607031318212 3 P17252,P48729 2 |
| Nanomaterial induced apoptosis 0.652589280668986 1.1492580819051086 0.250449577331123 1.0 0.5935607031318212 5 O95831 1 |
| Cardiac hypertrophic response 0.6502754084373745 1.1477223351041834 0.2510832077545775 1.0 0.5935607031318212 6 P50750,P42345,P31751,P63000 4 |
| Synaptic vesicle pathway 0.5121776677393861 1.14497571814885 0.2522192160890668 1.0 0.5938707438591175 13 P50570,O95782,Q96CW1,Q13277,O00429,P63010,P12235,O94973 8 |
| Joubert syndrome 0.4640809966101183 1.1314633047927185 0.2578601398437175 1.0 0.5999816639670749 16 Q13432,Q10713,P42345,P61586 4 |
| Phosphoinositides metabolism 0.6433542478573759 1.11888243802718 0.2631902961076484 1.0 0.6052352723720631 6 Q8TBX8,Q13614,Q9C0I1 3 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.5877659330892082 1.1119971432071585 0.2661393786470225 1.0 0.6065585852171675 9 Q13547,Q8WX92,P50750 3 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.62449690482354 1.102703448414708 0.2701559687661188 1.0 0.6115295313300051 7 Q99653,P11802,Q9UHD1 3 |
| Transcription cofactors ski and skil protein partners 0.6389524117005605 1.0866284335633127 0.2772010537979597 1.0 0.6197038311166523 4 Q13547 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5400847192991151 1.0838876198887573 0.2784146294042329 1.0 0.6197038311166523 11 Q96AY3,P13674,Q32P28 3 |
| Autophagy 0.619860401236186 1.08275056709923 0.2789191524146015 1.0 0.6197038311166523 7 Q99570,P54619,P42345 3 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6221730844227207 1.0183561702856212 0.3085087234450285 1.0 0.6673109573740204 4 Q07812 1 |
| Praderwilli and angelman syndrome 0.6153636581227822 1.0028960861069245 0.3159110012375783 1.0 0.6673109573740204 6 P42771,P11802,Q05086 3 |
| Glycosylation and related congenital defects 0.5053221716117478 1.0025188481317835 0.3160930680529581 1.0 0.6673109573740204 12 Q13724,P34949,Q9NP73,O60762,Q9BT22 5 |
| Nitric oxide metabolism in cystic fibrosis 0.6176566049983812 1.0000564022721472 0.3172832132353633 1.0 0.6673109573740204 4 Q86X55,O14744,O60678 3 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.613908207348972 0.9969014935806442 0.3188123266441371 1.0 0.6679751100048943 6 Q13547,P31751 2 |
| Pyrimidine metabolism 0.3593913109669941 0.9947466780290872 0.3198594858399071 1.0 0.6679751100048943 39 P04183,P62487,P31350,O75414,P62875,Q9NRF8,P17812,P49005,O15514,Q9H773,Q9NR33,O15160,O14802,P56282,P19387 15 |
| Nucleotide metabolism 0.5395153600891631 0.9898074915201313 0.3222682224179636 1.0 0.6706356318627341 10 P30520 1 |
| 15q112 copy number variation syndrome 0.6045739969629396 0.94727564973988 0.3434983355261933 1.0 0.7000259182620009 4 Q96CW5 1 |
| Caloric restriction and aging 0.5352812272089456 0.9387721965686776 0.3478477167623497 1.0 0.7038419751641992 3 P43490 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.5669814462673954 0.9202814764918672 0.357425686371484 1.0 0.713310250764637 8 Q05086,P54619,P42345,P31751 4 |
| Glial cell differentiation 0.4651313655530191 0.9157213366625456 0.3598130710910945 1.0 0.7135890101169021 2 P09543 1 |
| Amyotrophic lateral sclerosis als 0.5636011253887371 0.9055186096029262 0.3651907055308503 1.0 0.7170355713246928 8 P63000,P07196,Q07812,P20339,P07197,O96008 6 |
| Kennedy pathway from sphingolipids 0.5915047890359573 0.8995471351596418 0.3683613011138447 1.0 0.7208659899280868 5 Q9UG56,Q9BVG9 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.4363553401056613 0.8924925532285561 0.3721289824534406 1.0 0.7240738557134482 15 Q14739,P62993,P50402,Q8WXH0,P42166,P61586,O94901 7 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.5896006320879884 0.8918919504046667 0.3724508496394048 1.0 0.7240738557134482 5 Q13131,P42345,Q96KB5 3 |
| Folate metabolism 0.4463893511954292 0.8872010294379586 0.3749706783027651 1.0 0.7265825274653579 14 P41440,P00374 2 |
| Regucalcin in proximal tubule epithelial kidney cells 0.5845026540111062 0.8768741954781721 0.3805549735187554 1.0 0.7349934292470081 6 Q07812 1 |
| Oxidative stress response 0.5809336345433511 0.8624738882677532 0.3884267960312892 1.0 0.7423355482367961 6 P09601,P10620,P00390 3 |
| Disruption of postsynaptic signaling by cnv 0.5708820746644249 0.8221552273091728 0.4109885568705032 1.0 0.7696595451726251 6 P61981,Q13555 2 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.571671324605494 0.8203780596025577 0.4120006191152807 1.0 0.7696595451726251 5 Q13418 1 |
| Gaba receptor signaling 0.5578003545577728 0.8203523055352047 0.4120152964096812 1.0 0.7696595451726251 7 O95782,Q96CW1,P80404,P63010 4 |
| Regulation of actin cytoskeleton 0.357751381404042 0.8190127599298695 0.4127791335738391 1.0 0.7696595451726251 30 Q14344,Q8TBX8,Q9UQB8,Q96F07,P61586 5 |
| Dna repair pathways full network 0.3226876846443184 0.8189249542605614 0.412829231505452 1.0 0.7696595451726251 48 P40938,Q9BXW9,Q9NVI1,P29372,P18887,P38398,P49005,Q9NR33,Q9UQ84,P56282,O14757,P49959,P41440 13 |
| Tp53 network 0.5697066953412904 0.8087961738401294 0.4186323974050614 1.0 0.7707531055027766 4 Q07812,Q13794 2 |
| Complement system 0.4983377476933838 0.7946707141411661 0.4268050721499767 1.0 0.7833596200019759 10 P08754,P17252,P48729,P07942,P26885 5 |
| Camkk2 pathway 0.5154199985752288 0.7815232079903487 0.4344948323727449 1.0 0.7885516744764535 9 P09601,Q13586,P42345 3 |
| Splicing factor nova regulated synaptic proteins 0.4167724909605681 0.780713575400292 0.4349709744150996 1.0 0.7885516744764535 15 Q9Y2J2,Q12955,Q9UBB6 3 |
| Physicochemical features and toxicityassociated pathways 0.4677121206368847 0.7275760272144303 0.4668731598745954 1.0 0.823880307237016 11 P61586,P07196 2 |
| Sars coronavirus and innate immunity 0.4262082387285058 0.7223942170568084 0.4700521413331935 1.0 0.8243347641777963 2 P42224 1 |
| Glutathione metabolism 0.5383689258423042 0.6946630636913536 0.4872664807747449 1.0 0.8459364125771965 6 O75874,P28161 2 |
| Serotonin htr1 group and fos pathway 0.5389909949533161 0.693341459502515 0.4880952905056244 1.0 0.8459364125771965 5 P63096,P08754,P61586 3 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.5375346869045217 0.6878021598617633 0.4915773758128239 1.0 0.8467759113624234 5 P11802,Q13794 2 |
| Head and neck squamous cell carcinoma 0.4263032662067265 0.685984027232151 0.492723180828357 1.0 0.8467759113624234 13 P42771,P42345,P31751,Q13131,Q14145,P11802 6 |
| Omega3 omega6 fatty acid synthesis 0.536041036169197 0.6857384966590726 0.4928780262414105 1.0 0.8467759113624234 6 O15254 1 |
| Amino acid metabolism 0.2997607339703599 0.6822822983840028 0.4950604640025648 1.0 0.847752567016519 53 P11310,P49419 2 |
| Micrornas in cardiomyocyte hypertrophy 0.4415830769726039 0.6802986524045003 0.4963153776441888 1.0 0.847752567016519 12 P61586,P42345,P31751,P50750 4 |
| Nucleotide excision repair 0.3593350260258554 0.6545673832343825 0.5127463298244164 1.0 0.8732941813436025 21 P41440 1 |
| Male infertility 0.3653569486573453 0.6275672507644832 0.5302874680008016 1.0 0.8928771897107515 18 P41440,P50750 2 |
| Spinal cord injury 0.3778287644548506 0.6220202950940054 0.53392852304101 1.0 0.8940084904355652 16 P61586,P11802,Q08722,O94813 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.3433443692787867 0.6219347611927531 0.5339847667068605 1.0 0.8940084904355652 24 P56937,Q15392,Q14739,P33121 4 |
| Leptin and adiponectin 0.5195525500577578 0.6182986479110291 0.5363784930139963 1.0 0.8954793485064175 4 P54619,P50416 2 |
| Nrf2are regulation 0.4895719849826256 0.5962715142277347 0.5509938576030418 1.0 0.9146374271825762 8 P09601 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.4527120691976573 0.5838546445918368 0.5593181101164633 1.0 0.9233435840190776 3 P19525 1 |
| Estrogen receptor pathway 0.4503116775991469 0.5742203515074878 0.5658186991551193 1.0 0.928885697779654 3 Q9HCL2 1 |
| Ampactivated protein kinase ampk signaling 0.3677983018421979 0.5681684159413273 0.569920615461625 1.0 0.933027932791746 16 P50416,P14635,P42345,P31751 4 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.502788597611882 0.5620276629773738 0.5740971717310965 1.0 0.9372691394836412 6 O95782,P61586,P63010 3 |
| Pathways affected in adenoid cystic carcinoma 0.3461547793760407 0.558184241964943 0.5767185801678241 1.0 0.9389550437443088 20 Q9UBU8,Q96RT1,Q96T88,Q99417,O75376,P38398,O14757 7 |
| Malignant pleural mesothelioma 0.2839970509290275 0.555788913628378 0.5783551651985659 1.0 0.9390326995394296 62 P67870,Q96T88,Q13131,Q07820,Q15047,P62993,P31751,P38398,P51812,Q08722,Q9HCK8,P05114,P07942,P11802,Q07812,O15294,Q4VCS5,P48729,P23588,Q99728,P42771,P42345,Q13616,P56545,Q99496,P54619,P24941,O95816 28 |
| Nuclear receptors metapathway 0.2899135785628072 0.5459938339259878 0.5850701757310892 1.0 0.9447444640903654 49 P11310,Q13451,P28161,Q13616,P50416,Q07812,P10620,Q99615,Q14145,P09601,P11802 11 |
| Neural crest cell migration during development 0.4842214563371796 0.5319952734290793 0.5947292691289081 1.0 0.9551222773238714 7 Q99570,P61586,P31751 3 |
| Apoptosis 0.4204226851583813 0.5153564920115846 0.606303929534582 1.0 0.9650280963830898 11 P42771,Q07812,Q13794 3 |
| Alpha 6 beta 4 signaling pathway 0.4680454119737487 0.5137470495961882 0.6074288525457012 1.0 0.9650280963830898 8 P42345,P62993,P63000,P17252,P61586 5 |
| Homologous recombination 0.4750243764824161 0.4988347662414623 0.6178957931323785 1.0 0.9712138663330736 7 P49005 1 |
| Dna irdamage and cellular response via atr 0.3050608912224085 0.4936288018096275 0.621568356115459 1.0 0.974394956138558 34 Q9BXW9,P78527,Q9NVI1,Q92900,P49736,P38398,Q9HAW4,Q8WXE1,P46063,P33993,Q9UQ84,P24941,P49959,O14757,P43246,Q99728,Q92878 17 |
| Hypertrophy model 0.3684722672721344 0.459658593375689 0.6457612947850468 1.0 0.9885411246856056 2 P06730 1 |
| Target of rapamycin tor signaling 0.4528666180019964 0.4583854269716824 0.6466755596345197 1.0 0.9885411246856056 8 Q13131,P42345,P63000,P54619 4 |
| G protein signaling pathways 0.3772893832794605 0.4546336264833278 0.649372838842176 1.0 0.9885411246856056 13 P63096,Q14344,P10644,Q02952,O43823,P08754,Q92667,P17252,P61586 9 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.4720866044995356 0.4531562024957044 0.6504362675317268 1.0 0.9885411246856056 4 P42224,P19525 2 |
| Glycerolipids and glycerophospholipids 0.4707153215251265 0.450960804595146 0.6520177985048745 1.0 0.9885411246856056 6 Q9UG56,Q9HCL2,Q9BVG9 3 |
| Cytosolic dnasensing pathway 0.4316692103002644 0.4394574501005018 0.6603301066969474 1.0 0.990495160045421 9 P62875,O15160,O14802,P19388,Q14258 5 |
| Metapathway biotransformation phase i and ii 0.317935650434842 0.4322406561207914 0.6655665132884812 1.0 0.9915429665332915 22 Q86UY6,P10620,P78417,Q7LGA3 4 |
| Tca cycle aka krebs or citric acid cycle 0.3298144854392263 0.4234839507434389 0.6719422056931177 1.0 0.9915429665332915 17 P48735 1 |
| Genes related to primary cilium development based on crispr 0.4257909064552219 0.4182743538484552 0.675746538265152 1.0 0.9915429665332915 9 Q96J42,Q10713 2 |
| Lung fibrosis 0.458217932159048 0.4103920514619203 0.6815183760909791 1.0 0.9915429665332915 6 P09601 1 |
| Nicotine effect on dopaminergic neurons 0.4560632865089508 0.4019952748287907 0.6876875037668961 1.0 0.993700036005466 4 P17252,Q00535 2 |
| Follicle stimulating hormone fsh signaling pathway 0.4463635057472287 0.3723634959329078 0.7096222289436951 1.0 1.0 4 P42345 1 |
| Melanoma 0.3693104591745502 0.3659408497344785 0.7144092136361733 1.0 1.0 12 P42771,P63000,P31751,Q07812,P11802 5 |
| Tcell activation sarscov2 0.430541505113917 0.3513651174211785 0.7253144484055816 1.0 1.0 7 Q07812,P42771,P42345 3 |
| Egfegfr signaling pathway 0.2775845386493456 0.3294020776995256 0.7418517975663808 1.0 1.0 34 P63010,P62993,P63000,P42345,O95782,Q96CW1,Q96J02,P51812,P41240,P17252,P20339,Q9P0J0 12 |
| Cannabinoid receptor signaling 0.3818542440611859 0.3266931628565265 0.7438999720111856 1.0 1.0 3 P17252 1 |
| Photodynamic therapyinduced ap1 survival signaling 0.4216023009692019 0.3247095322063826 0.7454009196145084 1.0 1.0 7 P42771,Q07812 2 |
| Estrogen signaling pathway 0.3318196561790466 0.3176833693555357 0.75072512754191 1.0 1.0 2 P17252 1 |
| Netrinunc5b signaling pathway 0.3932131306434249 0.3100986662103808 0.7564859265165196 1.0 1.0 9 Q8TCG1,P63000,P61586,P30154 4 |
| Wnt signaling 0.3270083268580382 0.3073575671596813 0.7585712224766472 1.0 1.0 14 P67870,P63000,Q13555,Q9HCK8,P17252,P48729,P61586 7 |
| Unfolded protein response 0.4223241213673706 0.3037411654754036 0.7613250932261375 1.0 1.0 4 Q13794 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3516218475924962 0.3026474184362211 0.7621585734234122 1.0 1.0 12 P50402,P42166,Q13547,P48729,O60725,P11802,P55209 7 |
| Eukaryotic transcription initiation 0.335123842712375 0.2896612217491273 0.7720754255634945 1.0 1.0 13 O15160,P19387,Q13418 3 |
| Nonalcoholic fatty liver disease 0.2465665439098109 0.2721021029330407 0.785543512626135 1.0 1.0 52 O43676,P13073,O95182,P09669,P31751,O95168,Q96J02,O96000,P08574,Q16718,Q9P0J0 11 |
| Bdnftrkb signaling 0.4093055503311573 0.269685509262518 0.787402209560397 1.0 1.0 4 P42345 1 |
| G13 signaling pathway 0.3163982888181595 0.2694188677339351 0.7876073684233351 1.0 1.0 14 Q13576,Q14344,P61586,Q7L576 4 |
| Dna irdouble strand breaks and cellular response via atm 0.2719447968832369 0.2541969257375315 0.7993434255278911 1.0 1.0 26 Q9BXW9,P42771,Q07812,Q9UQ84,P49959,O14757,Q00535 7 |
| Pancreatic adenocarcinoma pathway 0.2861038588101171 0.2456142126847936 0.8059808860783897 1.0 1.0 18 P42771,P42345,P31751,Q07812,P61586,P11802 6 |
| Leukocyteintrinsic hippo pathway functions 0.397191239461977 0.2400997515056012 0.8102529268482819 1.0 1.0 4 P61586 1 |
| Parkinubiquitin proteasomal system pathway 0.261673482896633 0.2387941075743413 0.8112652395504332 1.0 1.0 31 Q9BUF5,O14936,Q13616,P54652,Q15008,P07437,Q99460,Q9BVA1,O00231,Q9Y385,P51665,O43242,P62333 13 |
| Modulators of tcr signaling and t cell activation 0.3673281263356176 0.2367500992713811 0.812850666010279 1.0 1.0 9 O96000,Q12824 2 |
| Tumor suppressor activity of smarcb1 0.2982107743454368 0.2116265962929721 0.832398358413956 1.0 1.0 14 Q12824 1 |
| Dna damage response only atm dependent 0.2700069323296362 0.2101635426904994 0.8335400328143259 1.0 1.0 21 P42771,P31751,Q13794,Q07812,Q99570,P61586 6 |
| Photodynamic therapyinduced unfolded protein response 0.3393616863137337 0.20017464343573 0.8413439974286607 1.0 1.0 10 Q13217,P05198 2 |
| Energy metabolism 0.3369772601386016 0.1944870059698345 0.8457945692120867 1.0 1.0 10 P54619,Q13555,Q13547,Q15648 4 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.2461558304640964 0.1939770687203237 0.8461938373726423 1.0 1.0 35 P63000,P67809,P42345,P29966,Q13131,P51812,Q96P70,Q7L576,Q00535,P05198 10 |
| Angiopoietinlike protein 8 regulatory pathway 0.256945444635957 0.1900450976740932 0.8492737916058308 1.0 1.0 24 P42345,P31751,P54619,P51812,Q99570,P41440,O14654 7 |
| 7q1123 copy number variation syndrome 0.2396473389112099 0.1873620074437134 0.8513768087396067 1.0 1.0 42 P00846,Q02218,Q9Y5Z9 3 |
| Nucleotide excision repair in xeroderma pigmentosum 0.2473204272903615 0.185283973999693 0.8530063072939529 1.0 1.0 31 P41440 1 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.3710628350579845 0.1835728468111701 0.8543485661901913 1.0 1.0 4 P51812 1 |
| Base excision repair 0.2651957423922491 0.1778698448895073 0.8588251934680984 1.0 1.0 18 P18887,P49005,Q9NR33 3 |
| Androgen receptor signaling pathway 0.249234006816248 0.1694117620700477 0.8654727724331188 1.0 1.0 25 O75376,Q86X55,P61586,Q05086 4 |
| Hijack of ubiquitination by sarscov2 0.3631486314186116 0.1684781021837805 0.8662071693502345 1.0 1.0 4 Q15369 1 |
| Nonsmall cell lung cancer 0.2908283310404648 0.1625377721085739 0.8708823858825314 1.0 1.0 13 P42771,P62993,P31751,Q07812,P11802 5 |
| Hepatitis c and hepatocellular carcinoma 0.3519432313002547 0.1586462384941174 0.8739475970451751 1.0 1.0 7 P38398,P63000,P31350 3 |
| Lipid metabolism pathway 0.2981334994900906 0.1548738426491806 0.8769207753474051 1.0 1.0 12 P12694,P31751,Q13131,P54619,P17252 5 |
| Small cell lung cancer 0.3048851418695516 0.1475290526904946 0.8827144498813522 1.0 1.0 11 P11802,Q07812,P31751 3 |
| Insulin signaling 0.2308418489255763 0.1448579409030925 0.8848230343885306 1.0 1.0 35 P17858,P31751,P63000,P42345,Q13131,O60343,P51812,Q99570,P41440,O00161,O14654 11 |
| Thiamine metabolic pathways 0.3464180925520906 0.1392263113638894 0.8892713175201004 1.0 1.0 5 Q02218,P12694 2 |
| Notch signaling pathway 0.278991774190951 0.1374032235487124 0.8907120831926176 1.0 1.0 13 O75376,Q96J02,Q13616 3 |
| Physiological and pathological hypertrophy of the heart 0.3440739358870274 0.1353374159631137 0.8923451035389087 1.0 1.0 6 P61586 1 |
| Cell migration and invasion through p75ntr 0.3432021749813903 0.1339910952429269 0.8934096159045672 1.0 1.0 6 P61586,P31751 2 |
| Pathogenic escherichia coli infection 0.2458288201478044 0.131973316137088 0.8950053977497676 1.0 1.0 19 Q16625 1 |
| Selenium micronutrient network 0.2927898014610296 0.1255315042426037 0.900102785517146 1.0 1.0 11 Q16881,Q8NFF5,Q8WTV0,P00390 4 |
| Ciliary landscape 0.2122476318963402 0.1110512971686929 0.9115756689990916 1.0 1.0 100 Q9Y312,P09669,P07196,Q15555,P25205,Q13868,Q13547,Q96P70,Q13576,Q9NQH7,Q16718,P07197 12 |
| Neural crest cell migration in cancer 0.3133536363355992 0.1086051516908034 0.9135156744696258 1.0 1.0 8 Q99570,P61586,P31751 3 |
| Alzheimers disease and mirna effects 0.2100309517467637 0.1011512707820962 0.9194303785192935 1.0 1.0 72 P67870,P60900,Q15008,P28072,Q99570,O00213,Q00535,P05198,P31751,Q99436,Q13564,P49721,Q96IX5,O14654,P28074,Q9NQC3,P25787,P12235,P48729,P42345,P20618,P19525,P28070 23 |
| Cohesin complex cornelia de lange syndrome 0.2249874304001579 0.091989346638322 0.9267065038532164 1.0 1.0 18 Q8N3U4,P30154 2 |
| Oxidation by cytochrome p450 0.3104495180196464 0.0917133596239864 0.9269257826848474 1.0 1.0 6 Q9UHQ9 1 |
| Measles virus infection 0.2159467209365242 0.0898312048570703 0.9284213505393047 1.0 1.0 23 O15372,P54652,Q07812,P24941,P11802,P05198 6 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2017568746488102 0.0849691857651059 0.932285888287673 1.0 1.0 32 Q8WU17,P42345,Q8WTV0,P48449,Q13131,P54619,P14324,O95487,P17252,Q9HCL2,O94979 11 |
| Myometrial relaxation and contraction pathways 0.2231660364300037 0.0821181503212287 0.9345527599999924 1.0 1.0 16 P61981,Q99439,Q13555,P17252,P78417 5 |
| Thyroid stimulating hormone tsh signaling pathway 0.2208479518118411 0.079466609545544 0.9366614893194564 1.0 1.0 16 Q14344,P11802,P42345 3 |
| Aryl hydrocarbon receptor pathway wp2586 0.2974991880480752 0.0792159459473191 0.9368608614177976 1.0 1.0 6 P28482,P07900,P24941,O00170,Q16543 5 |
| Complement system in neuronal development and plasticity 0.2866155909108301 0.079063219900498 0.936982338167306 1.0 1.0 8 Q07812 1 |
| Il6 signaling pathway 0.2888121723583478 0.0759777819743182 0.9394367745111412 1.0 1.0 7 Q13547,P63000 2 |
| Pi3kakt signaling pathway 0.1928334257373921 0.0757019135561227 0.9396562535667484 1.0 1.0 34 P62993,P31751,P63000,P30154,P42345,P38398,Q13131,Q07820,P24941,P17252,P23588,P06730,P11802 13 |
| Erbb signaling pathway 0.2331291967285721 0.0730031120862081 0.9418036410342994 1.0 1.0 13 P62993,P42345,P31751,Q13555,P17252 5 |
| Tnfalpha signaling pathway 0.2188759466728283 0.072484941870836 0.9422159885913816 1.0 1.0 15 Q07812,P63000,Q13616 3 |
| Hippo signaling regulation pathways 0.2126972219273076 0.0711873947316237 0.9432486135111724 1.0 1.0 16 P42345,P63000,P10644,P08754,Q13131,P54619,P17252,P61586 8 |
| Nanoparticlemediated activation of receptor signaling 0.2852969814995169 0.0693250328920632 0.9447309003019272 1.0 1.0 4 P62993,Q9Y490,P28482 3 |
| Il2 signaling pathway 0.2845079571289461 0.0688437042334136 0.9451140296407884 1.0 1.0 6 P42224,P62993,P28482,P62753,P46109 5 |
| Pdgf pathway 0.2640732572786821 0.0686938918970694 0.9452332802802864 1.0 1.0 9 P61586,P63000 2 |
| Epo receptor signaling 0.2844155844155892 0.0686648054242319 0.9452564332588522 1.0 1.0 5 Q15118,P42224,P28482,P62993 4 |
| Bladder cancer 0.2831899555311806 0.06778254183147 0.945958741396064 1.0 1.0 5 P11802 1 |
| Cholesterol biosynthesis pathway 0.2301136202174565 0.0637202203107183 0.9491930039844068 1.0 1.0 12 P48449,O75845 2 |
| Primary focal segmental glomerulosclerosis fsgs 0.2015389172639083 0.062252811909741 0.9503615061867348 1.0 1.0 16 Q9Y5K6,Q13418 2 |
| Leptin signaling pathway 0.1962939241218492 0.0613421885197372 0.9510866924642488 1.0 1.0 20 P62993,P63000,P42345,Q07812,Q13131,P61586 6 |
| Alzheimers disease 0.1903680385801396 0.0609840733618208 0.9513718930614674 1.0 1.0 71 P67870,P60900,Q15008,P28072,Q99570,O00213,Q00535,P05198,P31751,Q99436,Q13564,P49721,O14654,P28074,Q9NQC3,P25787,P12235,P48729,P42345,P20618,P19525,P28070 22 |
| Gastric cancer network 2 0.2160838533139672 0.0603177689373492 0.9519025501464908 1.0 1.0 13 P40938,Q14739 2 |
| Agerage pathway 0.2216114842495937 0.058505992497765 0.9533455893501372 1.0 1.0 12 P39656,P61586,P63000 3 |
| Kisspeptinkisspeptin receptor system in the ovary 0.2664252316894326 0.0573743437210341 0.9542470000724376 1.0 1.0 5 P31751 1 |
| Ranklrank signaling pathway 0.2448719897513525 0.0567992660359285 0.954705098614438 1.0 1.0 9 P42345,P31751 2 |
| Wnt signaling pathway and pluripotency 0.1911635642506928 0.0540693769939641 0.9568798901629828 1.0 1.0 15 P61586 1 |
| Pdgfrbeta pathway 0.2516755053020253 0.0508976581348081 0.9594070716306844 1.0 1.0 6 P19525,P62993 2 |
| Translation inhibitors in chronically activated pdgfra cells 0.1732972649384592 0.0492296439227825 0.96073628746679 1.0 1.0 16 P17252,P23588,P42345,P31751 4 |
| Hepatitis b infection 0.1719412724306721 0.048309925084686 0.9614692447172316 1.0 1.0 20 P05771,P42224,Q16531,P28482,Q15904,P63104,P40763,P12004,P62993,P31751,Q15750,O00571,P49327,Q07812,P27348,Q7Z434,Q9Y277,P31946,P17252 19 |
| Interactome of polycomb repressive complex 2 prc2 0.2416368950958188 0.0473574412621859 0.9622283478907314 1.0 1.0 6 O75530,Q15022,P55199,Q9NYF8,Q9Y2W1 5 |
| Glycogen synthesis and degradation 0.1829427083333357 0.0473088551958745 0.962267070560946 1.0 1.0 13 P63151,P30153,Q15257,P30154,P46976,P13807,P19367,Q14738,P06737,P35573,P52789,P11216 12 |
| Tolllike receptor signaling pathway 0.2342975446169255 0.0467734881556143 0.9626937592866384 1.0 1.0 7 P31751 1 |
| Kit receptor signaling pathway 0.1715494791666694 0.0452241877907979 0.9639286149018648 1.0 1.0 13 P40763,P05771,P42224,P62993,P46108,P07948,P28482,P62753,P51812,P17252,P46109,Q15418 12 |
| S1p receptor signal transduction 0.2275197444787512 0.0449786659883994 0.964124313816227 1.0 1.0 7 P63096,P08754,P31751 3 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.2256442236355177 0.044534046805763 0.9644787134622224 1.0 1.0 7 Q13555,Q15648 2 |
| Embryonic stem cell pluripotency pathways 0.2141077007789906 0.0436000776460042 0.9652231898054576 1.0 1.0 8 P31751 1 |
| Oncostatin m signaling pathway 0.1619897063103466 0.041843961169106 0.9666230897381828 1.0 1.0 11 P24941,P62993,P42345 3 |
|
|
